V
Viridian Therapeutics, Inc.
VRDN · NASDAQ · Healthcare · 2.5B
Closing price
$18.66
+1.74% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.2×
Enterprise value / EBITDAEV/EBITDA
-4.2×
Free cash flow yieldFCF yield
-17.5%
Return on equityROE
-47.4%
Operating margin
-512.9%
Net debt / EBITDAbalance-sheet strength
0.5×
Interest coverage
-73.4×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.